The PI3K/Akt pathway plays a crucial role in insulin signaling, and concurrent corticosteroid therapy, commonly used to manage peritumoral inflammation and hydrocephalus in DMG, further exacerbates glucose dysregulation. The gene discussed is PIK3CA; the disease is Hydrocephalus.